These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11468513)

  • 1. Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene: results from a murine tumour model.
    Wack C; Becker JC; Bröcker EB; Lutz WK; Fischer WH
    Melanoma Res; 2001 Jun; 11(3):247-53. PubMed ID: 11468513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response.
    Wack C; Kirst A; Becker JC; Lutz WK; Bröcker EB; Fischer WH
    Cancer Immunol Immunother; 2002 Oct; 51(8):431-9. PubMed ID: 12202904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunochemotherapy of malignant melanoma. Epifocal administration of dinitrochlorobenzene (DNCB) combined with systemic chemotherapy with dacarbazine (DTIC)].
    Trcka J; Kämpgen E; Becker JC; Schwaaf A; Bröcker EB
    Hautarzt; 1998 Jan; 49(1):17-22. PubMed ID: 9522188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: results of a nationwide survey of the German Dermatologic Co-operative Oncology Group.
    Terheyden P; Kortüm AK; Schulze HJ; Durani B; Remling R; Mauch C; Junghans V; Schadendorf D; Beiteke U; Jünger M; Becker JC; Bröcker EB
    J Cancer Res Clin Oncol; 2007 Jul; 133(7):437-44. PubMed ID: 17334785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical CpG enhances the response of murine malignant melanoma to dacarbazine.
    Najar HM; Dutz JP
    J Invest Dermatol; 2008 Sep; 128(9):2204-10. PubMed ID: 18368132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: a randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group.
    Punt CJ; Suciu S; Gore MA; Koller J; Kruit WH; Thomas J; Patel P; Lienard D; Eggermont AM; Keilholz U
    Eur J Cancer; 2006 Nov; 42(17):2991-5. PubMed ID: 17023156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of dacarbazine (DTIC) in preventing metastases arising from intraocular melanomas in mice.
    Sanborn GE; Niederkorn JY; Gamel JW
    Graefes Arch Clin Exp Ophthalmol; 1992; 230(2):192-6. PubMed ID: 1577304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical dinitrochlorobenzene combined with systemic dacarbazine in the treatment of recurrent melanoma.
    Strobbe LJ; Hart AA; Rümke P; Israels SP; Nieweg OE; Kroon BB
    Melanoma Res; 1997 Dec; 7(6):507-12. PubMed ID: 9464624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The nonspecific epifocal Malek-Mansour immunotherapy of malignant cutaneous melanoma using DNCB].
    Illig L; Paul E
    Hautarzt; 1976 Dec; 27(12):579-87. PubMed ID: 1010745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a novel somatostatin analogue combined with cytotoxic drugs on human tumour xenografts and metastasis of B16 melanoma.
    Szende B; Horváth A; Bökönyi G; Kéri G
    Br J Cancer; 2003 Jan; 88(1):132-6. PubMed ID: 12556972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials.
    Huncharek M; Caubet JF; McGarry R
    Melanoma Res; 2001 Feb; 11(1):75-81. PubMed ID: 11254118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adjuvant DNCB immunotherapy in malignant melanoma].
    Weidner F; Djawari D
    Z Hautkr; 1979 May; 54(10):436-43. PubMed ID: 473840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-DR5 monoclonal antibody-mediated DTIC-loaded nanoparticles combining chemotherapy and immunotherapy for malignant melanoma: target formulation development and in vitro anticancer activity.
    Ding B; Wu X; Fan W; Wu Z; Gao J; Zhang W; Ma L; Xiang W; Zhu Q; Liu J; Ding X; Gao S
    Int J Nanomedicine; 2011; 6():1991-2005. PubMed ID: 21976975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of chemotherapy with HVJ-E containing Rad51 siRNA elicited diverse anti-tumor effects and synergistically suppressed melanoma.
    Kiyohara E; Tamai K; Katayama I; Kaneda Y
    Gene Ther; 2012 Jul; 19(7):734-41. PubMed ID: 21900962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro and in-vivo inhibition of melanoma growth and metastasis by the drug combination of celecoxib and dacarbazine.
    Sadhu SS; Wang S; Averineni RK; Seefeldt T; Yang Y; Guan X
    Melanoma Res; 2016 Dec; 26(6):572-579. PubMed ID: 27540834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance.
    Spiro T; Liu L; Gerson S
    Forum (Genova); 2000; 10(3):274-85. PubMed ID: 11007934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research on the anti-tumour effect of steroid lactam alkylator (NSC-294859) in comparison with conventional chemotherapeutics in malignant melanoma.
    Trafalis DT; Camoutsis C; Papageorgiou A
    Melanoma Res; 2005 Aug; 15(4):273-81. PubMed ID: 16034305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosurgical approach to the treatment of malignant melanoma using 2,4-dinitrochlorobenzene (DNCB).
    Lukács L; István M
    Neoplasma; 1984; 31(4):437-45. PubMed ID: 6472514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of O(6)-methylguanine-DNA methyltransferase in melanoma tumours in patients treated with dacarbazine-based chemotherapy.
    Ma S; Egyházi S; Martenhed G; Ringborg U; Hansson J
    Melanoma Res; 2002 Aug; 12(4):335-42. PubMed ID: 12170182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine.
    Revskaya E; Jongco AM; Sellers RS; Howell RC; Koba W; Guimaraes AJ; Nosanchuk JD; Casadevall A; Dadachova E
    Clin Cancer Res; 2009 Apr; 15(7):2373-9. PubMed ID: 19293257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.